(Q36697494)

15 August 2017

1 reference

title

Valproic Acid: second generation (English)

1 reference

15 August 2017

Meir Bialer

1

1 reference

15 August 2017

Boris Yagen

series ordinal

2

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

4

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

130-137

1 reference

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Pros and cons for the development of new antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

The new antiepileptic drugs: pharmacological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

New antiepileptic drugs currently in clinical trials: is there a strategy in their development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

New antiepileptic drugs that are second generation to existing antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Diverse mechanisms of antiepileptic drugs in the development pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Valproate: a simple chemical with so much to offer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Valproic Acid-Induced Neural Tube Defects in Mouse and Human: Aspects of Chirality, Alternative Drug Development, Pharmacokinetics and Possible Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepilepti

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Pharmacologic evaluation of various metabolites and analogs of valproic acid: teratogenic potencies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

CYP2E1-mediated modulation of valproic acid-induced hepatocytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Characterization of the anticonvulsant profile and enantioselective pharmacokinetics of the chiral valproylamide propylisopropyl acetamide in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Tetramethylcyclopropyl analogue of a leading antiepileptic drug, valproic acid. Synthesis and evaluation of anticonvulsant activity of its amide derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Efficacy of antiepileptic tetramethylcyclopropyl analogues of valproic acid amides in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Clinical pharmacology of valpromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Efficacy of antiepileptic isomers of valproic acid and valpromide in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Could valerian have been the first anticonvulsant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Anticonvulsant profile and teratogenicity of N-methyl-tetramethylcyclopropyl carboxamide: a new antiepileptic drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Preclinical evaluation of 2,2,3,3-tetramethylcyclopropanecarbonyl-urea, a novel, second generation to valproic acid, antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Pharmacokinetics and metabolism of a new potent antiepileptic drug, 2,2,3,3-tetramethycyclopropanecarbonylurea, in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Reduction in diabetes-induced craniofacial defects by maternal immune stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Valproate decreases inositol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Anticonvulsant profile of valrocemide (TV1901): a new antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Anti-tumor mechanisms of valproate: a novel role for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Valproate and valproate-analogues: potent tools to fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Correlation analysis between anticonvulsant ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Valproate induces replication-independent active DNA demethylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2006.11.007

Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid.

21 January 2018

1 reference

12 December 2020

Pharmacokinetic analysis and antiepileptic activity of tetra-methylcyclopropane analogues of valpromide

1 reference

12 December 2020

Stereoselective pharmacokinetics and pharmacodynamics of propylisopropyl acetamide, a CNS-active chiral amide analog of valproic acid

1 reference

12 December 2020

1 reference

12 December 2020

Teratology study of derivatives of tetramethylcyclopropyl amide analogues of valproic acid in mice

1 reference

12 December 2020

Stereoselective pharmacokinetic analysis of valnoctamide in healthy subjects and in patients with epilepsy

1 reference

12 December 2020

Valrocemide (Teva/Acorda).

1 reference

12 December 2020

Pharmacokinetic analysis and antiepileptic activity of N-valproyl derivatives of GABA and glycine

1 reference

12 December 2020

Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity

1 reference

12 December 2020

New generation of valproic acid.

1 reference

12 December 2020

Valproate: Recent Findings and Perspectives

1 reference

12 December 2020

Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid

1 reference

12 December 2020

Target-Specific Neuropeptide Y-Ergic Synaptic Inhibition and Its Network Consequences within the Mammalian Thalamus

1 reference

12 December 2020

Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats.

1 reference

12 December 2020

Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII)

1 reference

12 December 2020

Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease

1 reference

12 December 2020

1 reference

12 December 2020

Structure-pharmacokinetic relationships in a series of short fatty acid amides that possess anticonvulsant activity

1 reference

12 December 2020

Divalproex and epilepsy

1 reference

12 December 2020

Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide

1 reference

12 December 2020

10.1016/J.NURT.2006.11.007

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1001383882

0 references

PMC publication ID

7479693

0 references

1 reference